{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T18:33:43Z","timestamp":1720809223169},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":65,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ebr.2024.100658","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:26:04Z","timestamp":1709835964000},"page":"100658","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Management of anhedonia after epilepsy surgery"],"prefix":"10.1016","volume":"26","author":[{"given":"Gerardo","family":"Maria de Araujo Filho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2024.100658_b0005","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ana.22117","article-title":"Groupe de r\u00e9flexion Sur l\u2019evaluation des fonctions ex\u00e9cutives study group: of dysexecutive syndrome: diagnostic criteria and validation study","volume":"68","author":"Godefroy","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebr.2024.100658_b0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/da.22490","article-title":"Treatment for anhedonia: a neuroscience driven approach","volume":"33","author":"Craske","year":"2016","journal-title":"Depress Anxiety"},{"issue":"8","key":"10.1016\/j.ebr.2024.100658_b0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1037\/amp0000059","article-title":"Liking, wanting, and the incentive-sensitization theory of addiction","volume":"71","author":"Berridge","year":"2016","journal-title":"Am Psychol"},{"issue":"2021","key":"10.1016\/j.ebr.2024.100658_b0020","first-page":"6319826","article-title":"Revisiting apathy in Alzheimer\u2019s disease: from conceptualization to therapeutic approaches","volume":"3","author":"Teixeira","year":"2021","journal-title":"Behav Neurol"},{"issue":"9","key":"10.1016\/j.ebr.2024.100658_b0025","first-page":"1","article-title":"Anhedonia as a transdiagnostic symptom across psychological disorders: a network approach","volume":"53","author":"Guineau","year":"2022","journal-title":"Psychol Med"},{"issue":"2","key":"10.1016\/j.ebr.2024.100658_b0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yebeh.2012.03.013","article-title":"Levetiracetam-associated loss of libido and anhedonia","volume":"24","author":"Calabr\u00f2","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2024.100658_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108966","article-title":"Anhedonia in epilepsy","volume":"140","author":"Roberts-West","year":"2023","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2024.100658_b0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/09540261.2017.1302412","article-title":"Psychiatric comorbidites in epilepsy","volume":"29","author":"Josephson","year":"2017","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.ebr.2024.100658_b0045","first-page":"1","article-title":"Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations","author":"Garcia","year":"2012","journal-title":"Epilepsy Res Treat"},{"issue":"6","key":"10.1016\/j.ebr.2024.100658_b0050","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1212\/WNL.0b013e31827b1ae0","article-title":"Depression in epilepsy: a systematic review and meta-analysis","volume":"80","author":"Fiest","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2024.100658_b0055","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/01.wnl.0000343850.85763.9c","article-title":"A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy","volume":"72","author":"Kanner","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2024.100658_b0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.seizure.2012.07.002","article-title":"Major depressive disorder as a predictor of a worse seizure outcome one year after surgery in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis","volume":"21","author":"De Araujo Filho","year":"2012","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.ebr.2024.100658_b0065","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/epi.13736","article-title":"Psychiatric lifetime diagnoses are associated with a reduced chance of seizure freedom after temporal lobe surgery","volume":"58","author":"Koch-Stoecker","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2024.100658_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103251","article-title":"Reward-based decision-making in mesial temporal lobe epilepsy patients with unilateral hippocampal sclerosis pre- and post-surgery","volume":"36","author":"Villa-Ballo","year":"2022","journal-title":"Neuroimage Clin"},{"issue":"Suppl 10","key":"10.1016\/j.ebr.2024.100658_b0075","first-page":"19","article-title":"Does a life-time history of depression predict a worse postsurgical seizure outcome following a temporal lobectomy?","volume":"60","author":"Kanner","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebr.2024.100658_b0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/7854_2021_228","article-title":"Can we anticipate and prevent the occurrence of iatrogenic psychiatric events caused by anti-seizure medications and epilepsy surgery?","volume":"55","author":"De Araujo Filho","year":"2022","journal-title":"Curr Top Behav Neurosci"},{"issue":"5","key":"10.1016\/j.ebr.2024.100658_b0085","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1528-1167.2011.03014.x","article-title":"Psychiatric outcomes of epilepsy surgery: a systematic review","volume":"52","author":"Macrodimitris","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2024.100658_b0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eplepsyres.2012.05.005","article-title":"Pre-surgical predictors for psychiatric disorders following epilepsy surgery in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis","volume":"102","author":"De Araujo Filho","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebr.2024.100658_b0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yebeh.2014.06.030","article-title":"Validation of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy","volume":"37","author":"Rathore","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2024.100658_b0100","doi-asserted-by":"crossref","unstructured":"Beck A, Steer R, Brown G. Beck Depression Inventory: Second Edition Manual. The Psychological Corporation; 1996.","DOI":"10.1037\/t00742-000"},{"key":"10.1016\/j.ebr.2024.100658_b0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/epi.17140","article-title":"ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy","volume":"63","author":"Mula","year":"2022","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ebr.2024.100658_b0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","article-title":"Rapid detection of major depression in epilepsy: a multicentre study","volume":"5","author":"Gilliam","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebr.2024.100658_b0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yebeh.2018.12.006","article-title":"Optimal cutoff score of the neurological disorders depression inventory for epilepsy (NDDI-E) for detecting major depressive disorder: a meta-analysis","volume":"92","author":"Kim","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.ebr.2024.100658_b0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/FPC.0000000000000392","article-title":"PharmGKB summary: sertraline pathway, pharmacokinetics","volume":"30","author":"Huddart","year":"2020","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"10.1016\/j.ebr.2024.100658_b0125","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ebr.2024.100658_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103251","article-title":"Reward-based decision-making in mesial temporal lobe epilepsy patients with unilateral hippocampal sclerosis pre- and post-surgery","volume":"36","author":"Villa-Ballo","year":"2022","journal-title":"Neuroimage Clin"},{"issue":"3","key":"10.1016\/j.ebr.2024.100658_b0135","first-page":"117","article-title":"Antidepressants in epilepsy","volume":"57","author":"Castanho-Monsalve","year":"2013","journal-title":"Rev Neurol"},{"issue":"12","key":"10.1016\/j.ebr.2024.100658_b0140","first-page":"CD010682","article-title":"Antidepressants for people with epilepsy and depression","author":"Maguire","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ebr.2024.100658_b0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yebeh.2016.03.022","article-title":"Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: a review of the evidence","volume":"61","author":"Kanner","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"Pt A","key":"10.1016\/j.ebr.2024.100658_b0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yebeh.2017.02.032","article-title":"The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: is it worth investigating?","volume":"70","author":"Ribot","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2024.100658_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2009.0238","article-title":"Antiepileptic drugs and psychopathology of epilepsy: an update","volume":"11","author":"Mula","year":"2009","journal-title":"Epileptic Disord"},{"issue":"4","key":"10.1016\/j.ebr.2024.100658_b0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"5 Suppl 2","key":"10.1016\/j.ebr.2024.100658_b0165","first-page":"S53","article-title":"Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders","volume":"53","author":"Ketter","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ebr.2024.100658_b0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/11539240-000000000-00000","article-title":"Duloxetine: clinical pharmacokinetics and drug interactions","volume":"50","author":"Knadler","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ebr.2024.100658_b0175","doi-asserted-by":"crossref","first-page":"988716","DOI":"10.3389\/fphar.2022.988716","article-title":"Comorbid epilepsy and depression-pharmacokinetic and pharmacodynamic drug interactions","volume":"13","author":"Miziak","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ebr.2024.100658_b0180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"Suppl 2","key":"10.1016\/j.ebr.2024.100658_b0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1528-1167.2006.00684.x","article-title":"Effects of antiepileptic drugs on mood and behavior","volume":"47","author":"Schmitz","year":"2006","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.ebr.2024.100658_b0190","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1002\/brb3.2222","article-title":"Lamotrigine for acute bipolar depression: An exploratory item-level analysis","volume":"11","author":"Peters","year":"2021","journal-title":"Brain Behav"},{"issue":"7","key":"10.1016\/j.ebr.2024.100658_b0195","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/epi.14444","article-title":"Psychological treatments for adults and children with epilepsy: evidence-based recommendations by the international league against epilepsy psychology task force","volume":"59","author":"Michaelis","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ebr.2024.100658_b0200","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ana.25561","article-title":"A trial of sertraline or cognitive behavior therapy for depression in epilepsy","volume":"86","author":"Gilliam","year":"2019","journal-title":"Ann Neurol"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986424000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986424000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T11:53:47Z","timestamp":1716638027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986424000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":40,"alternative-id":["S2589986424000157"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2024.100658","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of anhedonia after epilepsy surgery","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2024.100658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100658"}}